Zing Forum

Reading

Application of Deep Learning in Neonatal Brain Injury Diagnosis: Neural Network Practice Based on MRI Image Segmentation

This article introduces a deep learning course project focusing on using neural networks to segment MRI images of brain injuries in infants with Hypoxic-Ischemic Encephalopathy (HIE), aiming to improve the timeliness and accuracy of early diagnosis and treatment.

深度学习医学影像图像分割MRI新生儿脑损伤HIE神经网络医疗AI
Published 2026-05-01 18:44Recent activity 2026-05-01 18:52Estimated read 9 min
Application of Deep Learning in Neonatal Brain Injury Diagnosis: Neural Network Practice Based on MRI Image Segmentation
1

Section 01

[Introduction] Application Practice of Deep Learning in Neonatal Brain Injury Diagnosis

This project is a deep learning course practice focusing on using neural networks to segment MRI images of brain injuries in neonates with Hypoxic-Ischemic Encephalopathy (HIE), aiming to improve the timeliness and accuracy of early diagnosis and treatment. This article will share insights from aspects such as background, technical solutions, training optimization, evaluation and validation, and clinical prospects, exploring the application value of AI in neonatal brain injury diagnosis.

2

Section 02

Background: Clinical Challenges in Neonatal HIE Diagnosis and the Value of AI

Hypoxic-Ischemic Encephalopathy (HIE) is a common neurological disease in neonates, caused by perinatal hypoxia, which can lead to severe neurodevelopmental disorders or even life-threatening conditions. MRI is the gold standard for diagnosing HIE and evaluating brain injuries, but manual interpretation is time-consuming and relies on doctors' experience; segmentation of brain injury lesions is crucial for quantifying damage and assessing prognosis, but automated segmentation faces challenges due to the complex structure of neonatal brains and variable lesion morphology. Medical image analysis is an important application direction of AI in the medical field, providing automated and standardized solutions for image diagnosis—especially in neonatal intensive care, where rapid and accurate diagnosis is of great significance for saving lives.

3

Section 03

Methods: Deep Learning Image Segmentation Technology and Project Scheme

Overview of Deep Learning Segmentation Technology

Convolutional Neural Networks (CNNs) are the mainstream technology in medical image analysis, capable of automatically learning hierarchical features without manual operator design; semantic segmentation (assigning category labels to each pixel) is commonly used in medical image segmentation, requiring precise delineation of lesion boundaries. U-Net is a classic architecture with an encoder-decoder structure and skip connections, balancing high-resolution details and deep semantic features.

Project Technical Scheme

  • Data Preprocessing: Intensity normalization (eliminating device parameter differences), denoising (Gaussian/non-local mean filtering), image registration (aligning images from different sequences), data augmentation (rotating/flipping/elastic deformation to expand samples).
  • Network Architecture: Designing a suitable architecture considering the characteristics of neonatal MRI (small size, rich details, low lesion contrast).
  • Loss Function: Optional Dice Loss (optimizing overlap), cross-entropy loss (pixel-level classification), or composite loss (balancing overlap and boundary accuracy).
4

Section 04

Model Training and Optimization Strategies

  • Training Data Construction: Requires a large number of expert-annotated MRI images of HIE patients, with annotations completed by experienced pediatric neuroradiologists as the gold standard for supervised learning.
  • Class Imbalance Handling: Adopt strategies such as weighted loss functions, oversampling small-area samples, and branch network design to address the issue (normal brain tissue accounts for a large proportion, while lesion areas are small).
  • Transfer Learning: Due to the difficulty in obtaining medical data, pre-trained weights from ImageNet can be used for initialization, or intermediate pre-training on public medical datasets can be performed to improve performance in small-sample scenarios.
5

Section 05

Model Evaluation and Validation Methods

  • Quantitative Indicators: Use standard metrics such as Dice Similarity Coefficient (measuring overlap), sensitivity (correctly identifying lesions), specificity (correctly excluding normal areas), and Hausdorff Distance (evaluating boundary accuracy).
  • Cross-Validation: Implement strict cross-validation to ensure generalization ability; since data comes from different devices/hospitals, cross-center validation is needed to evaluate the model's robustness under different scanning conditions.
6

Section 06

Clinical Application Prospects and Challenges

Application Prospects

  • Auxiliary Diagnosis: Provide objective quantitative indicators (lesion volume, location), reduce subjective judgment differences, and improve diagnostic consistency and repeatability.
  • Real-Time Analysis: The model has fast inference speed, completing segmentation of a single MRI image in seconds, supporting rapid decision-making in emergency scenarios.

Challenges

  • Data Privacy and Ethics: Strict protection of patient privacy is required;
  • Regulatory Approval: Medical AI products need to undergo clinical trials and regulatory approval;
  • Doctor Acceptance: Workflow changes and trust building are needed;
  • Model Interpretability: Doctors need to understand the decision-making basis to avoid black-box predictions.
7

Section 07

Project Significance and Insights

This project demonstrates the potential of AI technology to solve practical clinical problems—it is not only an academic exercise but also explores a feasible path for automated diagnosis of neonatal brain injuries; open-source sharing reflects the academic community's positive attitude towards promoting the development of medical AI. For medical image AI researchers, it provides a complete process reference from data preparation to model training. It also reminds us that technical success is only the first step; real clinical value requires strict validation and prudent deployment.